C. Villegas

Myc-epitope tagged proteins detected with the 9E10 antibody in immunofluorescence and immunoprecipitation assays but not in Western blot analysis

H. Fan, A. K. Chan, C. Villegas, 1998 .

The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments.

J. Wright, H. Fan, C. Villegas, 1997, Proceedings of the National Academy of Sciences of the United States of America.

A link between ferritin gene expression and ribonucleotide reductase R2 protein, as demonstrated by retroviral vector mediated stable expression

Jim A. Wright, H. Fan, C. Villegas, 1996, FEBS letters.

The mammalian ribonucleotide reductase R2 component cooperates with a variety of oncogenes in mechanisms of cellular transformation.

J. Wright, H. Fan, C. Villegas, 1998, Cancer research.

Ribonucleotide reductase R2 component is a novel malignancy determinant that cooperates with activated oncogenes to determine transformation and malignant potential.

J. Wright, H. Fan, C. Villegas, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Suppression of malignancy by the 3' untranslated regions of ribonucleotide reductase R1 and R2 messenger RNAs.

J. Wright, J A Wright, A Huang, 1996, Cancer research.